Wegovy Wegovy (semaglutide) is a prescription medication that has been approved for weight management in adults with obesity or overweight, with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
However, cell-damage could be induced by abundant production of free radicals that in turn can trigger malfunctions such as cancer or neurodegeneration
Excellent service, top-quality products, and fast delivery
At $12,000 a year for Wegovy, treating 226 patients for two years would cost Medicare, private insurers and patients about $5.4 million
But the only formulation that has been extensively tested in clinical trials are those manufactured by the drug companies, she pointed out